Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Laekna, Inc. ( (HK:2105) ) has provided an update.
Laekna, Inc. has announced its upcoming annual general meeting scheduled for June 3, 2025, in Shanghai, China. The meeting will address several key resolutions, including the adoption of financial statements, re-election of directors, and re-appointment of KPMG as auditor. Additionally, the company seeks approval for the directors to have the authority to issue additional shares, which could impact the company’s capital structure and shareholder value.
More about Laekna, Inc.
Laekna, Inc. is a company incorporated in the Cayman Islands with limited liability, and it is listed on the Stock Exchange of Hong Kong. The company operates in the pharmaceutical industry, focusing on the development and commercialization of innovative therapies.
Average Trading Volume: 5,255,855
Technical Sentiment Signal: Strong Buy
For a thorough assessment of 2105 stock, go to TipRanks’ Stock Analysis page.